Duckers Eric 4
4 · BioCardia, Inc. · Filed Aug 8, 2019
Insider Transaction Report
Form 4
BioCardia, Inc.BCDA;BCDAW
Duckers Eric
Chief Medical Officer
Transactions
- Conversion
Common Stock
2019-08-06$3.00/sh+8,435$25,305→ 8,435 total - Purchase
Convertible promissory note
2019-07-05$25000.00/shExercise: $8.00From: 2019-07-05Exp: 2020-01-05→ Common Stock (3,125 underlying) - Conversion
Convertible promissory note
2019-08-06Exercise: $3.00From: 2019-07-05Exp: 2020-01-05→ Common Stock (8,435 underlying) - Purchase
Warrant (right to buy)
2019-08-06+8,435→ 8,435 totalExercise: $6.30From: 2019-08-06Exp: 2024-08-06→ Common Stock (8,435 underlying)
Footnotes (1)
- [F1]These securities were issued upon automatic conversion of a Convertible Promissory Note (the "Note") purchased pursuant to a Note Purchase Agreement dated July 5, 2019, by and between the Issuer and certain investors. The principal and accrued and unpaid interest on the Note was immediately convertible into shares of common stock at $8.00 per share or, if the Note remained outstanding at the time of the closing of a public offering of the Registrant, was subject to conversion into the securities offered in the public offering at 50% of the price to the public for such securities in such offering. The Registrant closed a public offering of units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock on August 6, 2019 at a price of $6.00 per unit and the Note converted in accordance with its terms into units at a price of $3.00 per unit.